Header Logo

Connection

AHMED ELKHANANY to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications AHMED ELKHANANY has written about Randomized Controlled Trials as Topic.
AHMED ELKHANANY
Connection Strength
0.042
Randomized Controlled Trials as Topic
  1. CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials. Lancet Oncol. 2026 May; 27(5):592-603.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.